HRT Financial’s CEL-SCI Corp CVM Stock Holding History

HRT Financial’s Portfolio CVM Stock Details CVM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$53K	Buy	+51,155	New	+$112K	﹤0.01%	3760
2026 Q1	–	Sell	-11,538	Closed	-$60K	–	3947
2025 Q4	$60K	Buy	+11,538	New	+$84.7K	﹤0.01%	2853
2025 Q1	–	Sell	-610	Closed	-$7K	–	2656
2024 Q4	$7K	Buy	+610	New	+$14.1K	﹤0.01%	2306
2022 Q2	–	Sell	-6,446	Closed	-$759K	–	3057
2022 Q1	$759K	Buy	6,446 +2,403	+59%	+$391K	0.01%	1247
2021 Q4	$861K	Buy	+4,043	New	+$1.24M	0.01%	1261
2020 Q4	–	Sell	-626	Closed	-$239K	–	1960
2020 Q3	$239K	Buy	+626	New	+$247K	0.01%	1263

Other funds holding CVM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

MCM

MAI Capital Management Independence, Ohio $26.6B AUM 22.97% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

HRT Financial's CVM Position: Q2 2026 in Review

HRT Financial opened a new position in CEL-SCI Corp (CVM) in Q2 2026: 51,155 shares worth $53K. The stake represents ﹤0.01% of the portfolio and ranks #3760 among its holdings. This is a return to the name: HRT Financial previously reported a position in CVM as recently as Q4 2025.

HRT Financial first reported a position in CVM in Q3 2020 and has held it in 6 quarters since. The position peaked at $861K in Q4 2021. 41 funds tracked by Wall St. Rank hold CVM as of Q2 2026.

HRT Financial held 51,155 shares of CEL-SCI Corp worth $53K as of Q2 2026.
CEL-SCI Corp was a new HRT Financial position in Q2 2026.
CEL-SCI Corp made up ﹤0.01% of HRT Financial's portfolio in Q2 2026, its #3760 holding.
HRT Financial first reported a position in CEL-SCI Corp in Q3 2020 and has held it in 6 quarters since.
HRT Financial's CEL-SCI Corp position peaked at $861K in Q4 2021.
41 funds tracked by Wall St. Rank held CEL-SCI Corp as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.